Complete remission in metastatic primary malignant melanoma of the esophagus with nivolumab: a case report

BACKGROUND: Primary malignant melanoma of the esophagus is a rare form of mucosal melanoma with a poor prognosis. While immune checkpoint inhibitors have recently extended overall survival in metastatic melanoma, data on their effects on primary malignant melanoma of the esophagus are limited becaus...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Takeshi, Nakano, Eriko, Yamauchi, Teruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278729/
https://www.ncbi.nlm.nih.gov/pubmed/34256852
http://dx.doi.org/10.1186/s13256-021-02928-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278729/
https://www.ncbi.nlm.nih.gov/pubmed/34256852
http://dx.doi.org/10.1186/s13256-021-02928-w

Ejemplares similares